Feature Channels: Digestive Disorders

Filters close
10-Apr-2012 6:00 AM EDT
Serious Complication of Gastrointestinal Procedure Can Be Avoided with Single Dose Medication
Michigan Medicine - University of Michigan

The procedure was a success, but afterwards 24-year-old Jessica Calcagno experienced stomach pain that she says was so unbearable she went to the emergency room. For the first time, a clinical trial, led by gastroenterologists at the University of Michigan, shows an effective way for patients like Jessica to avoid post-ERCP pancreatitis, a common and painful complication of a procedure to diagnose digestive health problems.

Released: 11-Apr-2012 11:00 AM EDT
Mayo Clinic Offers Newly Approved Treatment for Acid Reflux Disease
Mayo Clinic

Mayo Clinic in Florida will be one of the first health care institutions in the United States to offer a newly approved device to treat gastroesophageal reflux disease (GERD).

Released: 4-Apr-2012 3:55 PM EDT
Antibody Therapy Prevents Gastrointestinal Damage Following Radiation Exposure in Mice
Memorial Sloan Kettering Cancer Center

A new study offers the first evidence of a drug capable of preventing lethal damage to the gastrointestinal (GI) tract caused by exposure to high levels of ionizing radiation, such as those occurring during a nuclear incident. There are currently no FDA-approved treatments or prophylactics available to manage the condition, known as radiation gastrointestinal syndrome (RGS), which is associated with weight loss, vomiting, diarrhea, dehydration, systemic infection, and – in extreme cases – septic shock and death.

Released: 3-Apr-2012 2:45 PM EDT
Lower GI Problems Plague Many With Rheumatoid Arthritis
Mayo Clinic

Add lower gastrointestinal (GI) problems such as ulcers, bleeding and perforations to the list of serious complications facing many rheumatoid arthritis patients. They are at greater risk for GI problems and gastrointestinal-related death than people without the disease, a Mayo Clinic study shows.

22-Mar-2012 8:00 AM EDT
Researchers Identify Drugs with Fewest Side-Effects for Treating Irritable Bowel Syndrome
Cedars-Sinai

Cedars-Sinai researchers have determined that two prevalent drug therapies – rifaximin and lubiprostone – offer some of the best options for treating irritable bowel syndrome, a widespread disorder that affects up to one in five Americans. The findings, based on an analysis of more than two dozen large-scale clinical trials, are contained in a peer-reviewed study published online by The American Journal of Medicine and set to appear in the publication’s April print edition.

13-Mar-2012 2:00 PM EDT
Researchers Identify Unexpected Player in Intestinal Immunity
Washington University in St. Louis

With every meal, immune cells in the intestine stand like sentries at a citadel, turning away harmful bacteria but allowing vitamins and nutrients to pass. Now, researchers at Washington University School of Medicine in St. Louis have identified the cells that chaperone food antigens, or proteins, in the intestine so that the immune system doesn’t mount an attack. Their discovery provides scientists with a potential target for therapies against inflammatory bowel disease, celiac disease and food allergies.

6-Mar-2012 10:45 AM EST
Researchers Find 5 Risk Biomarkers for Crohn’s Disease In Jews of Eastern European Descent
Mount Sinai Health System

In the largest study of its kind, researchers from Mount Sinai School of Medicine have discovered five new genetic mutations associated with Crohn’s disease in Jews of Eastern European descent, also known as Ashkenazi Jews.

Released: 14-Feb-2012 6:00 AM EST
Children with IBD Have Difficulty in School, Mostly Due to Absences
Nationwide Children's Hospital

Children with inflammatory bowel disease (IBD) may have difficulty functioning in school, particularly because their tendency to internalize problems can impact attendance. These are the findings from a Nationwide Children’s Hospital study appearing in the Journal of Developmental & Behavioral Pediatrics.

Released: 8-Feb-2012 9:40 AM EST
Radiofrequency Ablation Helps Patients with Chronic Heartburn (Treating Barrett’s Esophagus Prevents Precancerous Dysplasia)
Greenwich Hospital

When chronic heartburn or acid reflux damages the lining of the esophagus it can create a condition called Barrett's esophagus, which may be precancerous. A minimally invasive outpatient procedure eradicates dysplasia to restore a healthy cell lining.

Released: 23-Jan-2012 2:00 PM EST
Diets High in Fiber Won't Protect Against Diverticulosis
University of North Carolina Health Care System

For more than 40 years, scientists and physicians have thought eating a high-fiber diet lowered a person’s risk of diverticulosis, a disease of the large intestine in which pouches develop in the colon wall. A new study of more than 2,000 people reveals the opposite may be true.

Released: 18-Jan-2012 5:10 PM EST
Combination of Oral Drugs Suppresses Common Type of Hepatitis C
Michigan Medicine - University of Michigan

A new combination of investigational drugs successfully suppressed hepatitis C genotype 1 infection in a high percent of patients who had not responded to previous treatment in a study led by a University of Michigan hepatologist.

Released: 22-Nov-2011 3:00 PM EST
Dendritic Cells Protect Against Acute Pancreatitis
NYU Langone Health

NYU Langone Medical Center researchers have discovered the novel protective role dendritic cells play in the pancreas. The new study, published in the November issue of journal Gastroenterology, shows dendritic cells can safeguard the pancreas against acute pancreatitis, a sudden dangerous swelling and inflammation of the pancreas gland.

Released: 16-Nov-2011 2:30 PM EST
Probiotic Protects Intestine from Radiation Injury
Washington University in St. Louis

Scientists at Washington University School of Medicine in St. Louis have shown that taking a probiotic before radiation therapy can protect the intestine from damage — at least in mice. Their study suggests that taking a probiotic also may help cancer patients avoid intestinal injury, a common problem in those receiving radiation therapy for abdominal cancers.

Released: 16-Nov-2011 12:25 PM EST
Research Team Works on New Solutions to Digestive Diseases
Atrium Health Wake Forest Baptist

As a researcher in neurogastroenterology for 40 years, professor Khalil Bitar has spent his professional life studying the causes of perplexing and what frequently become embarrassing problems for humans—issues such as constipation, diarrhea and colon disease.



close
2.18845